In IL-13Rα2-positive pancreatic cancer, the possibility of celiac plexus invasion can be predicted in advance of surgery, and it may be possible to manage the pain in the patients receiving chemotherapy. The gene discussed is IL13RA2; the disease is familial pancreatic carcinoma.